Adding to the toolbox: Receptor tyrosine kinases as potential targets in the treatment of hepatitis C

JOURNAL OF HEPATOLOGY

卷:56

Article

Jilg, Nikolaus¹  Chung, Raymond T.¹ 

[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA

关键词: HCV;    HCV entry;    Entry factors;    EGFR;    Host factors;    Receptor tyrosine kinases;   

DOI  :  10.1016/j.jhep.2011.06.020

来源: Elsevier

【 摘 要 】

Hepatitis C virus (HCV) is a major cause of liver disease, but therapeutic options are limited and there are no prevention strategies. Viral entry is the first step of infection and requires the cooperative interaction of several host cell factors. Using a functional RNAi kinase screen, we identified epidermal growth factor receptor and ephrin receptor A2 as host cofactors for HCV entry. Blocking receptor kinase activity by approved inhibitors broadly impaired infection by all major HCV genotypes and viral escape variants in cell culture and in a human liver chimeric mouse model in vivo. The identified receptor tyrosine kinases (RTKs) mediate HCV entry by regulating co-receptor associations and viral glycoprotein-dependent membrane fusion. These results identify RTKs as previously unknown HCV entry cofactors and show that tyrosine kinase inhibitors have substantial antiviral activity. Inhibition of RTK function may constitute a new approach for prevention and treatment of HCV infection. (C) 2011 European Association for the study of the Liver. Published by Elsevier B.V. All rights reserved.

【 授权许可】

Free